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Comparison of Inspiratory Muscle Strength Training
Effects Between Older Subjects With and Without
Chronic Obstructive Pulmonary Disease
Chien-Hui Huang,1 Gee-Gwo Yang,2 Ying-Tai Wu,3 Chih-Wei Lee1,4*
Background/Purpose: Inspiratory muscle strength training (IMST) has been traditionally recommended
for patients with chronic obstructive pulmonary disease (COPD) to improve respiratory strength. Respiratory
strength is reduced as age increases. However, few studies have focused on the effects of IMST on older
adults without COPD.
Methods: Subjects were divided into training non-COPD (TNC, n = 24) and training COPD (TC, n = 12)
according to their forced expiratory volume in 1 second (% predicted). Both groups received 6 weeks of
IMST, with training at 75–80% of maximal inspiratory pressure using pressure threshold trainers. A sec-
ond group of COPD subjects served as controls (CC, n = 24), which received no training. Dyspnea was
measured using the basic dyspnea index. Health-related quality of life was measured using the SF-36. The
SF-36 subcategories, physical component summary and mental component summary were compared. 
A 6-minute walk test was performed to determine functional status. Two-way repeated measures analysis
of variance was used to compare group effects and training effects of IMST.
Results: Maximal inspiratory pressure was increased in both training groups (TNC: 59.1 cmH2O pre-IMST
to 82.5 cmH2O post-IMST; TC: 53.2 to 72.6), but not in the CC group. Therefore, the basic dyspnea index
was improved in both training groups (TNC: 9.6 to 10.8; TC: 6.2 to 7.3). Functional status was improved
in the TNC group (TNC: 392.1 m to 436.3 m), but not in the TC or CC groups. Quality of life was improved
in the physical component summary in both training groups.
Conclusion: IMST increases maximal inspiratory pressure, relieves dyspnea and improves health-related
quality of life in older adults. IMST especially improves functional status in subjects without COPD. IMST
benefits subjects with COPD and those without COPD. Therefore, IMST as a treatment tool is not confined
to patients with COPD.
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Aging causes decreases in the strength of respira-
tory muscle, accompanied by a decrease in elas-
tic recoil of the lung and compliance of the chest
wall.1 The combination of the above changes re-
sults in increased work of breathing, which often
leads to the sensation of dyspnea. Patients with
chronic obstructive pulmonary disease (COPD)
experience increased resistance to airflow, air-
trapping and lung hyperinflation. Lung hyperin-
flation leads to the inspiratory muscle having 
a mechanical disadvantage, which causes further
weakness in addition to the aging process.
Dyspnea is an unpleasant sensation of breath-
ing. Once the respiratory muscle becomes weaker,
respiratory motor drive is heightened to main-
tain effective ventilation.2 Increased drive can
lead to the sensation of dyspnea. The relationship
between increased motor drive and respiratory
sensation has been investigated and a positive
correlation found.3 Research has shown that after
inspiratory muscle strength training (IMST), sub-
jects show a decreased inspiratory drive, which is
correlated with an increase in maximal inspira-
tory pressure (PImax).4 These results suggest that
changing inspiratory muscle strength does not
change pulmonary mechanics, but that it can
alter respiratory sensations, which is believed to
be beneficial to older adults, especially subjects
with COPD.
To date, IMST has for the most part been per-
formed in patients with COPD to improve inspi-
ratory muscle strength to relieve the sensation of
dyspnea.5,6 We consider that IMST could benefit
older adults without COPD as well. We designed
a high intensity/low repetition training program
to improve muscle strength. Dyspnea was eva-
luated using the basic dyspnea index (BDI). The
6-minute walk test (6MWT) was conducted to de-
termine whether functional walking performance
would change with IMST. Since health-related
quality of life (HRQOL) is the ultimate goal for
individuals with and without disease, we also
compared quality of life using the SF-36. A group
of age- and sex-matched subjects with COPD were
recruited.
Materials and Methods
Subjects
The study subjects were 36 patients with moder-
ate to severe COPD and 24 age- and sex-matched
subjects with normal lung function. Subjects with
COPD were recruited from previously diagnosed
patients, under regular treatment from one hos-
pital in eastern Taiwan. The study was approved
by the Institutional Review Board in Tzu Chi
Medical Center. Informed consent was obtained
from each subject.
The inclusion criteria for subjects with COPD
were those who were previously diagnosed with
COPD, with a forced expiratory volume in 1 sec-
ond (FEV1) less than 80% of predicted, stable
medication and no infection in the month prior
to entering the study. Subjects with COPD were
divided into training or control groups. Subjects
without COPD were mostly recruited from a
local senior recreation center, and some were
from a physical therapy clinic. The inclusion cri-
teria for subjects without COPD were normal
FEV1 (%predicted) and FEV1/forced vital capacity
(FVC). All the participants were required to be able
to walk during the experiment. Therefore, there
were three groups in the current study: training
non-COPD (TNC), training COPD (TC) and con-
trol COPD (CC). Throughout the study period,
subjects were informed not to change their med-
ication and lifestyle. Baseline characteristics of
the three groups are shown in Table 1.
Outcome measurements
Weight and height were measured and the body
mass index was calculated. Body composition was
assessed by bioelectrical impedance (Biospace
Inbody 3.0 Body Composition Analyzer, Singapore)
to give a body fat percentage.
Inspiratory muscle strength
PImax was measured at the mouth by a pressure
manometer (RPM, Micro, Cardinal Health,
Basingstoke, UK). Subjects were seated in a com-
fortable chair upright with nose clips on. After
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exhaling to residual volume, subjects placed their
lips around a mouthpiece and inspired as forcefully
as possible. Repeated measurements were taken at
least five times, with a 60- to 120-second rest be-
tween trials, until three measurements within 10%
variation were obtained. The average of these three
measurements was recorded as the subjects’ PImax.
Pulmonary function
Spirometry was performed according to American
Thoracic Society guidelines.7 Pulmonary function
tests were assessed after the inhalation of bron-
chodilators was withheld for at least 12 hours.
Dyspnea
Resting dyspnea was evaluated with the BDI. The
BDI includes three domains (functional impair-
ment, magnitude of task, and magnitude of effort)
with each measurement from 0 to 4, with 0 being
the strongest breathlessness at rest to 4 being
breathlessness only at the most strenuous activ-
ity. The scores from each domain were added to-
gether to form a BDI score. Exercise dyspnea was
evaluated using the visual analogue scale (VAS)
as explained below.
Functional walking
The 6MWT was conducted according to guide-
lines recommended in an official ATS statement.8
Dyspnea, as measured with the VAS, oxygen satu-
ration (SaO2) and pulse rate were measured at
the start and end of the 6MWT. VAS was mea-
sured using a horizontal line, 100 mm in length,
anchored by the word descriptors “no dyspnea at
all” and “very severe dyspnea” at each end. Subjects
were asked to mark on the line the point that
represented their perception of their state. The
VAS score was determined by measuring in mil-
limeters from the left hand end of the line to the
point that the patient marked. The distance that
the subjects covered in 6 minutes was recorded
as the 6MWD.
HRQOL
HRQOL was evaluated using the SF-36 Chinese
version, a general health profile commonly used
in clinical settings.9 The instrument includes 36
questions in eight dimensions of health. The SF-
36 can be self-administered or conducted by the
researcher. We chose to conduct the SF-36 our-
selves to avoid situations such as missed questions
or illiteracy. All subjects were questioned by the
same interviewer. The totals were then transformed
into a score from 0 to 100, with 0 and 100 as-
signed to the lowest and highest possible scores,
respectively. The SF-36 has been factor analyzed
and reduced to two summary scores. The physi-
cal component score (PCS) represents the four
physical health scales (i.e. physical functioning,
role physical, bodily pain, and general health per-
ceptions), while the mental health score (MCS)
reflects the four mental health scales (i.e. mental
health, role emotional, vitality, and social func-
tioning). We used both individual scale scores and
summary scores (PCS and MCS) in our analysis.
IMST protocol
The subjects received 6 weeks of IMST. The train-
ing was conducted 5 days per week. Every Monday,
Wednesday and Friday, subjects performed IMST
under supervision. The training was performed
individually under supervision by the same ex-
perimenter (CH) through the whole training pe-
riod. The other 2 days (Tuesday and Thursday)
subjects performed IMST at home by themselves
and were asked to keep a diary. Each subject used
a custom-designed pressure threshold inspiratory
muscle trainer, a device that provides a pressure
threshold load to inspiration between 14 cmH2O
and 80 cmH2O. The trainer permits unimpeded
exhalation. Each daily IMST session consisted of
four sets of six training breaths. Every Monday
the experimenter measured the subjects’ PImax
and adjusted the pressure threshold to 75% of
the current PImax.
Data analysis
Baseline pre-IMST data were evaluated with de-
scriptive statistics to characterize group differences.
Changes after IMST were evaluated by two-way
repeated analysis of variance (group×pre-training/
post-training) for dyspnea, 6MWD, and HRQOL
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(PCS and MCS). For all statistical analyses, a critical
value for p less than 0.05 was considered statisti-
cally significant.
Results
All subjects completed 6 weeks of IMST and post-
IMST tests. There were no differences in height,
weight, age, body mass index, body fat percent-
age, and PImax among the three groups (Table 1).
There was no difference in lung function between
the two COPD (TC and CC) groups.
Six weeks of IMST resulted in a significant in-
crease in PImax in both training groups, but not
in the control group (Figure 1), which amounted
to a 39% (p < 0.01), 36% (p < 0.01) and 6% (p >
0.05) increase in the TNC, TC, and CC groups,
respectively.
The BDI in TNC was significantly higher than
that in the TC and CC groups before the IMST
began, indicating that the dyspnea level was higher
in subjects with COPD than those without COPD.
IMST improved BDI (less dyspnea) in the TNC and
TC groups, but not in the CC group (Figure 2).
There was no difference in 6MWD pre-IMST
among the groups. After IMST, 6MWD was im-
proved only in the TNC group (Figure 3). IMST
significantly decreased the VAS in the TNC group,
but not in the TC group.
The SF-36 was completed by all subjects. Within
eight domains of the SF-36, there were three do-
mains where the TNC group was significantly bet-
ter than both the TC and CC groups, and these
were physical function, role limitations and gen-
eral health. IMST improved five domains in the
TNC group, four domains in the TC group and
Table 1. Anthropometric and clinical characteristics of the subjectsa
TNC TC CC
Age (yr) 70.6 ± 4.8 73.0 ± 6.3 70.8 ± 9.1
n (F:M) 24 (2:22) 12 (1:11) 24 (2:22)
Height (cm) 164.4 ± 6.9 159.5 ± 6.3 160.6 ± 5.1
Weight (kg) 67.5 ± 10.3 58.3 ± 13.1 58.8 ± 10.8
BMI (kg/m2) 24.7 ± 3.1 23.0 ± 5.5 22.8 ± 4.3
Body fat (%) 25.5 ± 7.7 22.2 ± 8.6 25.3 ± 4.5
FEV1 (% predicted) 103.8 ± 21.2 47.9 ± 9.0b 43.4 ± 19.3b
FVC (% predicted) 99.6 ± 18.3 67.1 ± 12.6b 60.8 ± 18.6b
FEV1/FVC 102.2 ± 10.6 69.8 ± 9.8b 65.9 ± 12.5b
Smoking (yes: no: ex) 3:12:9 1:2:9 5:2:17
PImax (cm/H2O) 59.1 ± 19.2 53.2 ± 23.6 58.8 ± 19.1
aData are presented as n or mean ± standard deviation; bsignificant difference compared with TNC (p < 0.05). F = female; M = male;
BMI = body mass index; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; PImax = maximal inspiratory 
pressure; TNC = training non-chronic obstructive pulmonary disease; TC = training chronic obstructive pulmonary disease; CC = control
chronic obstructive pulmonary disease.
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Figure 1. Effect of IMST on PImax among the groups.
Data are shown as mean ± SEM. *p < 0.01. TNC = training
non-chronic obstructive pulmonary disease; TC = training
chronic obstructive pulmonary disease; CC= control chronic
obstructive pulmonary disease; IMST = inspiratory muscle
strength training; PImax = maximal inspiratory pressure.
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one domain in the CC group (Table 2). Two-way
repeated measures analysis of variance showed 
a significant interaction between groups and
pre/post IMST in PCS (p < 0.001). PCS, but not
MCS, calculated from the SF-36, was improved
in both training groups (Figure 4). PCS in the
TNC group was significantly higher than that in
the CC and TC groups before IMST.
Discussion
Our study showed that 6 weeks of IMST increased
PImax, and this was accompanied by an increased
6MWD, lowered dyspnea and better HRQOL in
subjects without COPD. For subjects with mod-
erate to severe COPD, IMST also results in a com-
parable increase in PImax, accompanied by a
Table 2. The SF-36 domain scale pre- and post-inspiratory muscle strength training among the groupsa
TNC TC CC
Pre-IMST Post-IMST Pre-IMST Post-IMST Pre-IMST Post-IMST
Physical function 83.3 ± 21.0 0.89 ± 19.1b 46.7 ± 31.2d 65.8 ± 23.6c 66.0 ± 22.0d 67.50 ± 21.9
Role physical 76.0 ± 41.4 87.5 ± 33.8 29.2 ± 43.7d 54.2 ± 49.8 43.8 ± 43.1d 47.9 ± 35.3
Bodily pain 66.2 ± 22.5 85.2 ± 17.8c 43.0 ± 27.0d 65.2 ± 22.8b 66.4 ± 24.0d,e 65.5 ± 18.9
General health 70.2 ± 18.8 75.6 ± 15.1b 44.6 ± 25.3d 57.5 ± 21.5b 49.8 ± 22.8d 51.0 ± 19.0
perception
Vitality 74.4 ± 19.0 80.2 ± 20.5b 52.9 ± 25.6d 62.5 ± 17.0 64.6 ± 27.8 67.5 ± 25.2b
Social function 75.0 ± 25.0 87.0 ± 17.9b 66.7 ± 30.8 81.3 ± 22.3b 83.3 ± 21.4 83.3 ± 19.4
Role emotional 79.2 ± 39.1 83.3 ± 35.4 41.7 ± 47.4d 55.6 ± 49.9 52.8 ± 46.0 56.9 ± 43.4
Mental health 78.0 ± 16.5 82.5 ± 14.2 59.0 ± 29.6 62.7 ± 23.2 71.5 ± 24.2 72.5 ± 21.7
aData are presented as mean ± standard deviation; bsignificant difference compared with pre-IMST within groups (p < 0.05); csignificant 
difference compared with pre-IMST within groups (p < 0.01); dsignificant difference compared with TNC pre-IMST (p < 0.05); esignificant 
difference compared with TC pre-IMST (p < 0.05). IMST = inspiratory muscle strength training; TNC = training non-chronic obstructive 
pulmonary disease; TC = training chronic obstructive pulmonary disease; CC = control chronic obstructive pulmonary disease; SD = standard
deviation.
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Figure 2. Effect of IMST on the basic dyspnea index among
the groups. Data are shown as mean ± SEM. *p < 0.01,
†p<0.05 compared with pre-IMST in the TNC group. TNC=
training non-chronic obstructive pulmonary disease; TC =
training chronic obstructive pulmonary disease; CC= control
chronic obstructive pulmonary disease; IMST = inspiratory
muscle strength training.
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Figure 3. Effect of IMST on the 6-minute walk distance
among the groups. Data are shown as mean ± SEM. *p <
0.01. TNC= training non-chronic obstructive pulmonary dis-
ease; TC = training chronic obstructive pulmonary disease;
CC= control chronic obstructive pulmonary disease; IMST=
inspiratory muscle strength training.
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better HRQOL. Because they are different health
indicators, each of these results will be discussed
separately.
The effect of IMST on PImax
The inspiratory muscle group is usually under a
higher demand but with lower capacity to per-
form in patients with COPD. The PImax in our
TC and CC groups was 53.2 and 58.8 cmH2O, 
respectively, while PImax in the TNC group was
59.1 cmH2O before IMST. It is difficult to deter-
mine a reasonable PImax level for patients with
COPD, because every individual has a different
disease severity and level of activity. For people
without COPD in the TNC group, it was found
that PImax was lower than that in subjects of 
a similar age but different ethnicity as reported
previously.10,11 This is consistent with other stud-
ies in which respiratory muscle strength in Asians
appears to be lower than that in Caucasians,12,13
although a definitive comparative study has not
yet been conducted. A study involving 13,005
African-American and Caucasian subjects sug-
gested that there was no race effect (Caucasian vs.
African American) on PImax.14 A database of
PImax among Taiwanese needs to be established,
followed by similar international comparative
research involving Taiwanese and other ethnicities.
The present training protocol used 75–80%
PImax as the training intensity and 24 breaths/
day over 6 weeks of training. This resulted in a
PImax increase of 39% and 36% in the TNC and
TC groups, respectively. The current study was
equally effective compared with the majority of
studies that used a lower PImax as training inten-
sity and with subjects training for 6–18 weeks.
Overload, specificity and reversibility are three prin-
ciples in designing training regimes to obtain a
desired training response. Leith and Bradely15
concluded that these principles are important 
in respiratory muscle training as well. Pressure-
threshold loading, as used in the current study,
requires the user to generate a preset threshold
(pressure) load to open a valve system, and it
therefore provides an effective stimulus for in-
creasing maximal pressure generating ability.
One study of Taiwanese subjects demonstrated
that 8 weeks of two 15-minute sessions a day could
result in a similar 39% increase of PImax.16 Con-
sidering the total training time spent, our study
was more efficient (6 weeks, ∼10 minutes a day).
Most of the literature on IMST for subjects
without COPD focuses on improving athletic
performance.17 There are very few applications of
IMST for counteracting the physiological changes
of aging among elderly subjects. Watsford and
Murphy18 concluded that 8 weeks of threshold
respiratory muscle training improved PImax by
20% among a group of women aged 60–69 years.
This finding showed that older people are capa-
ble of responding to inspiratory strength training.
Our study demonstrated that even older subjects
(> 70 years old), and those under high intensity
training (75–80%), can respond in a very favor-
able direction to IMST.
The effect of IMST on dyspnea
Dyspnea appears to arise from the mismatch be-
tween inspiratory motor command and afferent
feedback from mechanoreceptors.1 Therapies ca-
pable of reducing this mismatch may ameliorate
dyspnea. Our results showed that dyspnea was
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Figure 4. Effect of IMST on the physical component sum-
mary among the groups. Data are shown as mean ± SEM.
*p < 0.01, †p < 0.05 compared with pre-IMST in the TNC
group, ‡p < 0.01 compared with pre-IMST in the TNC
group. TNC = training non-chronic obstructive pulmonary
disease; TC = training chronic obstructive pulmonary dis-
ease; CC = control chronic obstructive pulmonary disease;
IMST = inspiratory muscle strength training.
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decreased in both training groups. IMST improves
inspiratory muscle strength via the hypertrophy of
muscle and neural adaptation. It has been reported
in healthy subjects that strength gained from IMST
correlates with a reduction in inspiratory motor
commands.4 Consistent with this finding, in our
study, the TNC and TC groups had reduced dysp-
nea levels after IMST. In a review paper by Hill 
et al,19 the authors found that IMST that induces
substantial improvements in PImax may also result
in substantial reductions in dyspnea. However, in
our study, when we further analyzed the relation-
ship between the difference in PImax and the dif-
ference in BDI in either training group, we found
no significant correlation (r = −0.17 for TNC; r =
−0.13 for TC). This is probably explained by the
ceiling effect, given the fact that the BDI values
reported in our subjects were relatively high pre-
IMST (TNC: 9.6; TC: 6.2). We believe that this is
because we recruited a group of subjects who had
either COPD or normal lung function; we did not
specifically recruit subjects experiencing dyspnea.
In our study, the significant improvement in BDI
after IMST was small but clinically relevant.
Exertion during exercise discourages people
from pursuing physical activity, which is especially
critical to preserving fitness in older adults. We
found that IMST significantly decreased the VAS in
the TNC group (before walking, 5.9; after walking,
17.0 pre-IMST; before walking, 2.7; after walking,
7.6 post-IMST). We found that there was a signif-
icant main effect of training in the TNC group
(p = 0.006) and an interaction (p = 0.021), which
suggests that subjects in the TNC group not only
felt less breathlessness after walking, but also felt
less breathlessness before walking post-IMST. This
significant interaction was not found in the TC
group (p = 0.09); however, we believe that this 
insignificant result is probably due to the small
number of subjects in this group (n = 12 in TC vs.
n = 24 in TNC). Studies using threshold devices
have been shown to increase the velocity of short-
ening and reduce inspiratory time during loaded
breathing tasks.20,21 This could contribute to less
dyspnea during exertion, because a reduced in-
spiratory time during exercise would increase 
expiratory time if the total respiratory cycle time
is the same. The increase in expiratory time could
also reduce dynamic hyperinflation that an aging
lung may experience.22 We demonstrated that both
at rest and after exertion, dyspnea was decreased
after IMST in the TNC group.
The effect of IMST on 6MWD
The 6MWT is frequently used to assess the func-
tional status and exercise capacity for patients with
COPD because it is inexpensive, safe, and valid.
In addition, the 6MWD has been shown to be a
good predictor of survival in patients with COPD.23
However, mean improvements of 44 m and 24 m
in the TNC and TC groups, respectively, meant
that only TNC significantly improved 6MWD in
our study.
According to the equations proposed by Enright
and Sherrill24 and by Troosters et al,25 subjects in
the TNC group obtained 83.7 ± 14.7% and 89.8 ±
16.2% of the predicted distance pre-IMST and
93.3 ± 17.3% and 100.3 ± 20.0% post-IMST, re-
spectively, suggesting that our Taiwanese healthy
adults walked less distance during the test (com-
pared to the publishing data which the subjects
were mainly Caucasians). The factors that con-
tributed to their below average performance are
unknown.
Improvement in the 6MWD in the TNC group
is compatible with previous studies. Puhan26 con-
cluded that for patients with COPD, an improve-
ment of at least 35 m represents an important
effect, which corresponds to a 10% change of base-
line 6MWD. In the current study, the TC group
improved by only 6.88%, which did not meet
the recommended minimal important difference.
Considering that the only intervention was IMST
and no other exercise program was offered, it is
not surprising that the TC group had limited im-
provement. Recently Cote et al27 followed 1,379
COPD patients for 55 months and found a thresh-
old value for 6MWD. They concluded that a value
less than 350m is associated with increased mortal-
ity and should be considered as abnormal. In our
TC subjects, after receiving IMST, subjects reached
the standard of 350 m.
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The effect of IMST on HRQOL
Since no cure is possible for most COPD patients,
the goal of clinical management is to improve
patients’ HRQOL. HRQOL also reflects a treat-
ment’s effect on the patient’s well-being that is
not reflected in physiological measures. Generic
HRQOL, the SF-36 Health Survey, was chosen in-
stead of disease specific QOL, because not all our
subjects had COPD. Nevertheless, the SF-36 has
been demonstrated to be reliable28 and respon-
sive in COPD subjects.29 IMST, which is a valuable
intervention intended to relieve the chief com-
plaint of COPD, improved HRQOL in both train-
ing groups. There was a significant difference in
all but two domains (social function and mental
health) between the TNC and TC groups before
IMST, indicating subjects with COPD felt less
healthy, with the exception of social function and
mental health, compared with subjects without
COPD of same age and sex. Previous research has
shown that the domains that exhibit the greatest
linear trend with dyspnea scores are role physical,
physical function and general health scales.30,31
Our results confirmed that these three domains
were significantly different between subjects with
and without COPD. For the two COPD groups,
there was no difference in seven out of eight do-
mains. The only difference found was in bodily
pain, where the CC group scored higher than the
TC group. Since the major complaint for COPD
patients is dyspnea and the grouping decision was
made mainly in accordance with the subjects’ pref-
erence, it is possible that CC subjects felt less dys-
pnea than TC subjects and chose not to participate
in IMST.
TNC improved five domains of HRQOL in
the SF-36, and these were physical function, bod-
ily pain, general health, vitality, and social func-
tion. TC subjects improved in the same domains
as TNC subjects with the exception of vitality. In
contrast, CC subjects only improved in vitality.
In the component scales, PCS was improved
in both training groups after IMST, which is con-
sistent with previous findings. Scherer et al32
found that PCS improved after respiratory mus-
cle endurance training. This was the first study to
demonstrate that hyperpnea training has a positive
effect on QOL. Our study was aimed at improving
respiratory strength, but it also showed improve-
ment in PCS. Similar results were observed by
Hill et al,33 who applied high intensity inspira-
tory muscle training in patients with COPD and
found that QOL was improved. Therefore, this is
one more positive effect of IMST.
We should mention two limitations of the
present study. First, our study included very few
women, because we had difficulty in recruiting
female patients for COPD groups. Second, we only
recruited stable patients from the outpatient clinic;
therefore, the study sample may not be represen-
tative of patients with moderate to severe COPD
who are incapable of making regular visits.
In conclusion, IMST has been used primarily on
pulmonary patients, and it has been shown that
IMST provides a positive effect on inspiratory mus-
cle strength, sensation of dyspnea, functional ca-
pacity and quality of life in patient populations.
Our study confirms this conclusion for older
people. In addition, for older people without pul-
monary disease, the current study showed that
IMST also improves inspiratory muscle strength,
sensation of dyspnea, functional capacity and qual-
ity of life. We conclude that the strength training
type of inspiratory muscle training can be recom-
mended to older adults with or without obstructive
symptoms to relieve dyspnea and improve QOL.
Acknowledgment
The authors would like to thank the Taiwan
National Science Council for financial support
(NSC93-2314-B-277-002).
References
1. Dyspnea. Mechanisms, assessment, and management: 
a consensus statement. American Thoracic Society. Am J
Respir Crit Care Med 1999;159:321–40.
2. Ferrari K, Goti P, Duranti R, et al. Breathlessness and 
control of breathing in patients with COPD. Monaldi Arch
Chest Dis 1997;52:18–23.
C.H. Huang, et al
526 J Formos Med Assoc | 2011 • Vol 110 • No 8
3. Redline S, Gottfried SB, Altose MD. Effects of changes in
inspiratory muscle strength on the sensation of respiratory
force. J Appl Physiol 1991;70:240–5.
4. Huang CH, Martin AD, Davenport PW. Effect of inspira-
tory muscle strength training on inspiratory motor drive
and RREP early peak components. J Appl Physiol 2003;
94:462–8.
5. Katsura H, Yamada K, Wakabayashi R, et al. The impact 
of dyspnoea and leg fatigue during exercise on health-
related quality of life in patients with COPD. Respirology
2005;10:485–90.
6. Weiner P, Magadle R, Beckerman M, et al. Maintenance
of inspiratory muscle training in COPD patients: one year
follow-up. Eur Respir J 2004;23:61–5.
7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R,
et al. Standardisation of spirometry. Eur Respir J 2005;26:
319–38.
8. ATS statement: guidelines for the six-minute walk test.
Am J Respir Crit Care Med 2002;166:111–7.
9. Fuh JL, Wang SJ, Lu SR, et al. Psychometric evaluation of a
Chinese (Taiwanese) version of the SF-36 health survey
amongst middle-aged women from a rural community.
Qual Life Res 2000;9:675–83.
10. Harik-Khan RI, Wise RA, Fozard JL. Determinants of 
maximal inspiratory pressure. The Baltimore Longitudinal
Study of Aging. Am J Respir Crit Care Med 1998;158:
1459–64.
11. Neder JA, Andreoni S, Lerario MC, et al. Reference values
for lung function tests. II. Maximal respiratory pressures
and voluntary ventilation. Braz J Med Biol Res 1999;32:
719–27.
12. Chan CC, Cheong TH, Wang YT, et al. Transdiaphragmatic
pressure in young adult Singaporean subjects—normal
values and a comparison between different respiratory
manoeuvres. Aust N Z J Med 1996;26:75–81.
13. Wang YT, Poh SC. Lung function and respiratory muscle
strength after propranolol in thyrotoxicosis. Aust N Z J Med
1986;16:496–500.
14. Carpenter MA, Tockman MS, Hutchinson RG, et al.
Demographic and anthropometric correlates of maximum in-
spiratory pressure: The Atherosclerosis Risk in Communities
Study. Am J Respir Crit Care Med 1999;159:415–22.
15. Leith DE, Bradley M. Ventilatory muscle strength and 
endurance training. J Appl Physiol 1976;41:508–16.
16. Hsiao SF, Wu YT, Wu HD, et al. Comparison of effective-
ness of pressure threshold and targeted resistance devices
for inspiratory muscle training in patients with chronic ob-
structive pulmonary disease. J Formos Med Assoc 2003;
102:240–5.
17. Sheel AW. Respiratory muscle training in healthy indivi-
duals: physiological rationale and implications for exercise
performance. Sports Med 2002;32:567–81.
18. Watsford M, Murphy A. The effects of respiratory-muscle
training on exercise in older women. J Aging Phys Act 2008;
16:245–60.
19. Hill K, Jenkins SC, Hillman DR, et al. Dyspnoea in COPD:
can inspiratory muscle training help? Aust J Physiother 2004;
50:169–80.
20. Flynn MG, Barter CE, Nosworthy JC, et al. Threshold pres-
sure training, breathing pattern, and exercise performance
in chronic airflow obstruction. Chest 1989;95:535–40.
21. Villafranca C, Borzone G, Leiva A, et al. Effect of inspiratory
muscle training with an intermediate load on inspiratory
power output in COPD. Eur Respir J 1998;11:28–33.
22. Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capac-
ity, dynamic hyperinflation, breathlessness, and exercise
performance during the 6-minute-walk test in chronic ob-
structive pulmonary disease. Am J Respir Crit Care Med
2001;163:1395–9.
23. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk
distance: change over time and value as a predictor of
survival in severe COPD. Eur Respir J 2004;23:28–33.
24. Enright PL, Sherrill DL. Reference equations for the six-
minute walk in healthy adults. Am J Respir Crit Care Med
1998;158:1384–7.
25. Troosters T, Gosselink R, Decramer M. Six minute walking
distance in healthy elderly subjects. Eur Respir J 1999;14:
270–4.
26. Puhan MA, Mador MJ, Held U, et al. Interpretation of
treatment changes in 6-minute walk distance in patients
with COPD. Eur Respir J 2008;32:637–43.
27. Cote CG, Casanova C, Marin JM, et al. Validation and com-
parison of reference equations for the 6-min walk distance
test. Eur Respir J 2008;31:571–8.
28. Mahler DA, Mackowiak JI. Evaluation of the short-form
36-item questionnaire to measure health-related quality
of life in patients with COPD. Chest 1995;107:1585–9.
29. Moy ML, Ingenito EP, Mentzer SJ, et al. Health-related
quality of life improves following pulmonary rehabilitation
and lung volume reduction surgery. Chest 1999;115:383–9.
30. Alonso J, Prieto L, Ferrer M, et al. Testing the measurement
properties of the Spanish version of the SF-36 Health
Survey among male patients with chronic obstructive pul-
monary disease. Quality of Life in COPD Study Group. 
J Clin Epidemiol 1998;51:1087–94.
31. Viramontes JL, O’Brien B. Relationship between symptoms
and health-related quality of life in chronic lung disease. 
J Gen Intern Med 1994;9:46–8.
32. Scherer TA, Spengler CM, Owassapian D, et al. Respiratory
muscle endurance training in chronic obstructive pulmonary
disease: impact on exercise capacity, dyspnea, and quality of
life. Am J Respir Crit Care Med 2000;162:1709–14.
33. Hill K, Jenkins SC, Philippe DL, et al. High-intensity inspira-
tory muscle training in COPD. Eur Respir J 2006;27:1119–28.
